GERMANY: PHARMACEUTICAL COMPANY CUREVAC RAISED 180 MILLION EURO IN ITS STOCK MARKET DEBUT

Highlights:

• On Friday, Germany’s biopharmaceutical company had generated 180 million euro in its debut in the stock market
• The company has sold its debut shares at a price of 13.3 million euro

CureVac which is the biopharmaceutical company that is also producing the vaccine for the novel corona virus, located in Tubingen, Germany has made its stock market debut and the ....